|
1
|
Dorta DJ, Curti C and Rodrigues T: Effects
of flavonoids on mitochondria: An overview on pharmacological and
toxicological aspects. Mitochondrial Pharmacology and Toxicology.
Moreno AJM, Oliveira PJ and Palmeira CM: Transworld Research
Network; Kerala, India: pp. 147–161. 2006
|
|
2
|
Agullo G, Gamet-Payrastre L, Manenti S,
Viala C, Remesy C, Chap H and Payrastre B: Relationship between
flavonoid structure and inhibition of phosphatidylinositol
3-kinase: A comparison with tyrosine kinase and protein kinase C
inhibition. Biochem Pharmacol. 53:1649–1657. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haddad AQ, Venkateswaran V, Viswanathan L,
Teahan SJ, Fleshner NE and Klotz LH: Novel antiproliferative
flavonoids induce cell cycle arrest in human prostate cancer cell
lines. Prostate Cancer Prostatic Dis. 9:68–76. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nair HK, Rao KV, Aalinkeel R, Mahajan S,
Chawda R and Schwartz SA: Inhibition of prostate cancer cell colony
formation by flavonoid quercetin correlates with modulation of
specific regulatory genes. Clin Diagn Lab Immunol. 11:63–69.
2004.PubMed/NCBI
|
|
5
|
Mokhtari MJ, Motamed N and Shokrgozar MA:
Evaluation of silibinin on the viability, migration, and adhesion
of the human prostate adenocarcinoma (PC-3) cell line. Cell Bio
Int. 32:888–892. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Daskiewicz JB, Depeint F, Viornery L, et
al: Effects of flavonoids on cell proliferation and caspase
activation in human colonic cell line HT29: an SAR study. J Med
Chem. 48:2790–2804. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Knowles LM, Zigrossi DA, Tauber RA,
Hightower C and Milner JA: Flavonoids suppress androgen-independent
human prostate tumor proliferation. Nutr Cancer. 38:116–122. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Skibola CF and Smith MT: Potential health
impacts of excessive flavonoid intake. Free Radic Biol Med.
29:375–383. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
MacGregor JT and Jurd L: Mutagenicity of
plant flavonoids: structural requirements for mutagenic activity in
Salmonella typhimurium. Mutat Res. 54:297–309. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carver JH, Carrano AV and MacGregor JT:
Genetic effects of the flavonols quercetin, kaempferol, and
galangin on Chinese hamster ovary cells in vitro. Mutat Res.
113:45–60. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bjeldanes LF and Chang GW: Mutagenic
activity of quercetin and related compounds. Science. 197:577–578.
1977. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brown JP and Dietrich PS: Mutagenicity of
plant flavonols in Salmonella/mammalian microsome test:
activation of flavonol glycosides by mixed glycosidases from rat
cecal bacteria and other sources. Mutat Res. 66:223–240.
1979.PubMed/NCBI
|
|
13
|
Hillard JJ, Krause HM, Brenstein JI,
Fernandez JA, Nguyen V, Ohemeng KA and Barrett JF: A comparison of
active binding of 4-quinolones and novel flavone gyrase inhibitors
to DNA gyrase. Adv Exp Med Biol. 390:59–69. 1995.PubMed/NCBI
|
|
14
|
Guthrie N and Manthey JA:
Antiproliferative activities of citrus flavonoids against six human
cancer cell lines. J Agric Food Chem. 50:5837–5843. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
García-Mediavilla V, Crespo I, Collado PS,
Esteller A, Sánchez-Campos S, Tuñón MJ and González-Gallego J: The
anti-inflammatory flavones quercetin and kaempferol cause
inhibition of inducible nitric oxide synthase, cyclooxygenase-2,
and reactive C-protein, and down-regulation of the nuclear factor
kappaB pathway in Chang Liver cells. Eur J Pharmacol. 557:221–229.
2007.
|
|
16
|
Kaushik D, O’Fallon K, Clarkson PM, Dunne
CP, Conca KR and Michniak-Kohn B: Comparison of quercetin
pharmacokinetics following oral supplementation in humans. J Food
Sci. 77:H231–H238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suomela JP, Ahotupa M, Yang B, Vasankari T
and Kallio H: Adsorption of flavonols derived from sea buckthorn
(Hippophae rhamnoides L.) and their effects on emerging risk
factors for cardiovascular disease in humans. J Agric Food Chem.
54:7364–7369. 2006.PubMed/NCBI
|
|
18
|
Manach C, Williamson G, Morand C, Scalbert
A and Rémésy C: Bioavailability and bioefficacy of polyphenols in
humans. I. Review of 97 bioavailability studies. Am J Clin Nutr.
81(Suppl 1): S230–S242. 2005.PubMed/NCBI
|
|
19
|
Del Rio DD, Borges G and Crozier A: Berry
flavonoids and phenolics: bioavailability and evidence of
protective effects. Br J Nutr. 104(Suppl 3): S67–S90.
2010.PubMed/NCBI
|
|
20
|
Gao S and Hu M: Bioavailability challenges
associated with development of anti-cancer phenolics. Mini Rev Med
Chem. 10:550–567. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Singh B, Mense SM, Bhat NK, Putty S,
Guthiel WA, Remotti F and Bhat HK: Dietary quercetin exacerbates
the development of estrogen-induced breast tumors in female ACI
rats. Toxicol Appl Pharmacol. 247:83–90. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yadegarynia S, Pham A, Ng A, et al:
Profiling flavonoid cytotoxicity in human breast cancer cell lines:
determination of structure-function relationships. Nat Prod Commun.
7:1295–1304. 2012.PubMed/NCBI
|
|
23
|
Chang H, Mi M, Ling W, et al: Structurally
related cytotoxic effects of flavonoids on human cancer cells in
vitro. Arch Pharm Res. 31:1137–1144. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Wang X, Ye H, Peng A and Chen L:
Barbigerone, an isoflavone, inhibits tumor angiogenesis and human
non-small-cell lung cancer xenografts growth through VEGFR2
signaling pathways. Cancer Chemother Pharmacol. 70:425–437. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu TC, Yang YC, Huang PR, Wen YD and Yeh
SL: Genistein enhances the effect of trichostatin A on inhibition
of A549 cell growth by increasing expression of TNF receptor-1.
Toxicol Appl Pharmacol. 262:247–254. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wesolowska O, Wiśniewski J, Sroda-Pomianek
K, et al: Multidrug resistance reversal and apoptosis induction in
human colon cancer cells by some flavonoids present in citrus
plants. J Nat Prod. 75:1896–1902. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vaid M, Prasad R, Singh T, Jones V and
Katiyar SK: Grape seed proanthocyanidins reactivate silenced tumor
suppressor genes in human skin cancer cells by targeting epigenetic
regulators. Toxicol Appl Pharmacol. 263:122–130. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee DH, Szczepanski M and Lee YJ: Role of
Bax in quercetin-induced apoptosis in human prostate cancer cells.
Biochem Pharmacol. 75:2345–2355. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gamet-Payrastre L, Manenti S, Gratacap MP,
Tulliez J, Chap H and Payrastre B: Flavonoids and the inhibition of
PKC and PI 3-Kinase. Gen Pharmacol. 32:279–286. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee LT, Huang YT, Hwang JJ, et al:
Transinactivation of the epidermal growth factor receptor tyrosine
kinase and focal adhesion kinase phosphorylation by dietary
flavonoids; effect on invasive potential of human carcinoma cells.
Biochem Pharmacol. 67:2103–2114. 2004. View Article : Google Scholar
|
|
31
|
Di Pietro A, Conseil G, Perez-Victoria JM,
et al: Modulation by flavonoids of cell multidrug resistance
mediated by P-glycoprotein and related ABC transporters. Cell Mol
Life Sci. 59:307–322. 2002.PubMed/NCBI
|
|
32
|
Politzer P, Lane P, Concha MC, Ma Y and
Murray JS: An overview of halogen bonding. J Mol Model. 13:305–311.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bruggisser R, von Daeniken K, Jundt G,
Schaffner W and Tullberg-Reinert H: Interference of plant extracts,
phytoestrogens, and antioxidants with MTT tetrazolium assay. Planta
Med. 68:445–448. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Molander GA and Biolatto B:
Palladium-catalyzed Suzuki-Miyaura cross-coupling reactions of
potassium aryl- and heteroaryltrifluoroborates. J Org Chem.
68:4302–4314. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Khan N, Afaq F, Syed DN and Mukhtar H:
Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle
arrest in human prostate cancer LNCaP cells. Carcinogenesis.
29:1049–1056. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Harborne JB, Grayer RF, Porter LF, et al:
The Flavonoids Advances in Research Since 1980. Harborne, New York:
pp. 399–420. 1988
|
|
37
|
Tanaka H, Stohlmeyer MM, Wandless TJ and
Taylor LP: Synthesis of flavonol derivatives as probes of
biological processes. Tetrahedron Lett. 41:9735–9739. 2000.
View Article : Google Scholar
|
|
38
|
Ichikawa M, Pamukcu AM and Bryan GT: A
convenient method for the synthesis of kaempferol. Org Prep Proced
Int. 14:183–187. 1982. View Article : Google Scholar
|
|
39
|
Urgaonkar S and Shaw JT: Synthesis of
kaempferitrin. J Org Chem. 72:4582–4585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Landini D, Montanari F and Rolla F:
Cleavage of dialkyl and aryl alkyl ethers with hydrobromic acid in
the presence of phase-transfer catalysts. Synthesis. 10:771–773.
1978. View Article : Google Scholar
|
|
41
|
Boumendjel A, Bois F, Beney C, Mariotte
AM, Conseil G and Di Pietro A: B-ring substituted
5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein
responsible for cell multidrug resistance. Bioorg Med Chem Let.
11:75–77. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Azimova SS and Vinogradova VIG: Galangin.
Natural Compounds: Flavonoids: Plant Sources, Structure and
Properties. Springer; New York: pp. 962013
|
|
43
|
Batirov EK, Kiyamitdinova F and Malikov
VM: Flavonoids of the epigeal part of Glycyrrhiza glabra.
Chem Nat Compd. 22:107–108. 1986. View Article : Google Scholar
|
|
44
|
Yuldashev MP: Flavonoids of the epigeal
part of Glycyrrhiza uralensis. Chem Nat Compd. 34:508–509.
1998. View Article : Google Scholar
|
|
45
|
Agrawal PK and Rastogi RP: 13C
NMR spectroscopy of flavonoids. Heterocycles. 16:21811981.
View Article : Google Scholar
|
|
46
|
Xu R, Zhang Y, Ye X, Xue S, Shi J, Pan J
and Chen Q: Inhibition effects and induction of apoptosis of
flavonoids on the prostate cancer cell line PC-3 in vitro. Food
Chem. 138:48–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Torkin R, Lavoie JF, Kaplan DR and Yeger
H: Induction of caspase-dependent, p53-mediated apoptosis by
apigenin in human neuroblastoma. Mol Cancer Ther. 4:1–11. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ferguson PJ, Kurowska E, Freeman DJ,
Chambers AF and Koropatnick DJ: A flavonoid fraction from cranberry
extract inhibits proliferation of human tumor cell lines. J Nutr.
134:1529–1535. 2004.PubMed/NCBI
|
|
49
|
Walle T, Ta N, Kawamori T, Wen X, Tsuji PA
and Walle UK: Cancer chemopreventive properties of orally
bioavailable flavonoids - methylated versus unmethylated flavones.
Biochem Pharmacol. 73:1288–1296. 2007. View Article : Google Scholar
|
|
50
|
Gosslau A, Chen M, Ho CT and Chen KY: A
methoxy derivative of resveratrol analogue selectively induced
activation of the mitochondrial apoptotic pathway in transformed
fibroblast. Br J Cancer. 92:513–521. 2005.
|
|
51
|
Berridge MV and Tan AS: Characterization
of the cellular reduction of
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT):
subcellular localization, substrate dependence, and involvement of
mitochondrial electron transport in MTT reduction. Arch Biochem
Biophys. 303:474–482. 1993. View Article : Google Scholar
|
|
52
|
Dunigan DD, Waters SB and Owen TC: Aqueous
soluble tetrazolium/formazan MTS as an indicator of NADH- and
NADPH-dependent dehydrogenase activity. Biotechniques. 19:640–649.
1995.PubMed/NCBI
|
|
53
|
Maeda H, Matsu-Ura S, Yamauchi Y and
Ohmori H: Resaurin as an electron acceptor in glucose
oxidase-catalyzed oxidation of glucose. Chem Pharm Bull.
49:622–625. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Suszynski TM, Wildey GM, Falde EJ, et al:
The ATP/DNA ratio is a better indicator of islet cell viability
than the ADP/ATP ratio. Transplant Proc. 40:346–350. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wisman KN, Perkins AA, Jeffers MD and
Hagerman AE: Accurate assessment of the bioactivities of
redox-active polyphenolics in cell culture. J Agric Food Chem.
56:7831–7837. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Maioli E, Torricelli C, Fortino V,
Carlucci F, Tommassini V and Pacini A: Critical appraisal of the
MTT assay in the presence of rottlerin and uncouplers. Biol Proced
Online. 11:227–240. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang P, Henning SM and Heber D:
Limitations of MTT and MTS-based assays for measurement of
antiproliferative activity of green tea polyphenols. PLoS One.
5:e102022010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang D, Liu Y, Chu L, et al: Relationship
between the structures of flavonoids and oxygen radical absorbance
capacity values: a quantum chemical analysis. J Phys Chem A.
117:1784–1794. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Pourcel L, Routaboul JM, Cheynier V,
Lepiniec L and Debeaujon I: Flavonoid oxidation in plants: from
biochemical properties to physiological functions. Trends Plant
Sci. 12:29–36. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Jacobs H, Moalin M, Bast A, van der Vijgh
WJ and Haenen GR: An essential difference between the flavonoids
monoHER and quercetin in their interplay with the endogenous
antioxidant network. PLoS One. 5:e138802010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang S, Yu H and Wickliffe JK: Limitations
of the MTT and XTT assays for measuring cell viability due to
superoxide formation induced by nano-scale TiO2. Toxicol
In Vitro. 25:2147–2151. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Stockert JC, Blázquez-Castro A, Cañete M,
Horobin RW and Villanueva A: MTT assay for cell viability:
Intracellular localization of the formazan product is in lipid
droplets. Acta Histochem. 114:785–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Tranzer JP and Pearse AG: Cytochemical
demonstration of ubiquinones in animal tissues. Nature.
199:1063–1066. 1963. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Carmichael J, DeGraff WG, Gazdar AF, Minna
JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated
colorimetric assay: assessment of chemosensitivity testing. Cancer
Res. 47:936–942. 1987.PubMed/NCBI
|
|
65
|
Shapiro AB and Ling V: Positively
cooperative sites for drug transport by P-glycoprotein with
distinct drug specificities. Eur J Biochem. 250:130–137. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Bennett MD, Price HJ and Johnston JS:
Anthocyanin inhibits propidium iodide DNA fluorescence in
Euphorbia pulcherrima: implications for genome size
variation and flow cytometry. Ann Bot. 101:777–790. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tajmir-Riahi HA, Diamantoglou S, Kanakis
CD, Tarantilis PA and Polissiou MG: Flavonoids interactions with
DNA and RNA: binding modes and antioxidative effects. Acta Hort.
744:195–204. 2007.
|
|
68
|
Baracca A, Sqarbi G, Solaini G and Lenaz
G: Rhodamine 123 as a probe of mitochondrial membrane potential:
evaluation of proton flux through F(0) during ATP synthesis.
Biochim Biophys Acta. 1606:137–146. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Shapiro AB and Ling V: Effect of quercetin
on Hoechst 33342 transport by purified and reconstituted
P-glycoprotein. Biochem Pharmacol. 53:587–596. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Liu Y, Peterson DA, Kimura H and Schubert
D: Mechanism of cellular
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
reduction. J Neurochem. 69:581–593. 1997. View Article : Google Scholar
|
|
71
|
Altman SA, Randers L and Rao G: Comparison
of trypan blue dye exclusion and fluorometric assays for mammalian
cell viability determinations. Biotechnol Prog. 9:671–674. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Smith AL and Smith HV: A comparison of
fluorescein diacetate and propidium iodide staining and in vitro
excystation for determining Giardia intestinalis cyst
viability. Parasitology. 99:329–331. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Mascotti K, McCullough J and Burger SR:
HPC viability measurement: trypan blue versus acridine orange and
propidium iodide. Transfusion. 40:693–696. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Szabo SE, Monroe SL, Fiorino S, Bitzan J
and Loper K: Evaluation of an automated instrument for viability
and concentration measurements of cryopreserved hemapoietic cells.
Lab Hematol. 10:109–111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Vijayababu MR, Arunkumar A, Kanagaraj P,
Venkataraman P, Krishnamoorthy G and Arunakaran J: Quercetin
downregulates matrix metalloproteinases 2 and 9 proteins in
prostate cancer (PC-3). Mol Cell Biochem. 287:109–116. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Hollman PC and Katan MB: Absorption,
metabolism and health effects of dietary flavonoids in man. Biomed
Pharmacother. 51:305–310. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Hollman PC, van Trijp JM, Mengelers MJ, de
Vries JH and Katan MB: Bioavailability of the dietary antioxidant
flavonol quercetin in man. Cancer Lett. 114:139–140. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Hollman PC, van Trijp JM, Buysman MN, van
der Gaag MS, Mengelers MJ, de Vries JH and Katan MB: Relative
bioavailability of the antioxidant flavonoid quercetin from various
foods in man. FEBS Lett. 418:152–156. 1997. View Article : Google Scholar : PubMed/NCBI
|
